SpineGuard Reports on Its Annual Shareholders’ Meeting of June 30, 2022
30 Juin 2022 - 06:00PM
Business Wire
Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company
that deploys its DSG (Dynamic Surgical Guidance) sensing technology
to secure and streamline the placement of bone implants, reports on
its Annual Shareholders’ Meeting held on June 30, 2022, at 10:00am,
on its second call at the offices of the law firm Ashurst Paris,
located at 18 square Edouard VII, 75009 Paris.
The shareholders present or represented were holding 7,847,972
shares representing a quorum of 25.14%.
All the resolutions of this Annual General Meeting were adopted
with the exception of the 17th resolution as recommended by the
Board of Directors.
The minutes of the shareholders' meeting will be available
within the legal deadlines on SpineGuard’s website:
www.spineguard.com.
Upcoming financial events: - H1 2022 revenue, July 12,
2022, after market - H1 2022 results, September 14, 2022, after
market
About SpineGuard® Founded in 2009 in France and the USA
by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative
company deploying its proprietary radiation-free real time sensing
technology DSG® (Dynamic Surgical Guidance) to secure and
streamline the placement of implants in the skeleton. SpineGuard
designs, develops and markets medical devices that have been used
in over 90,000 surgical procedures worldwide. Nineteen studies
published in peer-reviewed scientific journals have demonstrated
the multiple benefits DSG® offers to patients, surgeons, surgical
staff and hospitals. Building on these strong fundamentals and
several strategic partnerships, SpineGuard has expanded the scope
of its DSG® technology in innovative applications such as the «
smart » pedicle screw, the DSG Connect visualization and
registration interface, dental implantology and surgical robotics.
DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger,
M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. SpineGuard
has engaged in multiple ESG initiatives.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220630005715/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel: +33 1 45
18 45 19 p.jerome@spineguard.com
SpineGuard Manuel Lanfossi CFO Tel: +33 1 45 18 45 19
m.lanfossi@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin / Pierre Laurent Tel.: +33 1 44 71 94 94
spineguard@newcap.eu
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024